Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Today, the FDA has expanded the benefits of Ozempic to a new patient population that needs critical treatment options to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease.
Beginning in month 5, the participant started experiencing renewed severe food preoccupation episodes despite maximal tirzepatide dosing
These include spicy foods, citrus fruits, tomatoes, chocolate, caffeine, and alcoholic beverages
Optometry Australia, which represents the largest community of optometrists in Australia, has said patients should not be unnecessarily alarmed by this update and do not need to stop taking a GLP-1 drug unless they have a change in their vision
It is not intended to diagnose, treat, cure, or prevent any disease and should not be relied upon as medical advice
